IPBS Prestige Seminar series - Cancer Immunity and Immunotherapy

Program

10h00 - Opening and welcome by Dr. Jean-Philippe Girard

10h10 - Prof. Laurence Zitvogel

10h40 - Prof. Wolf Hervé Fridman

11h10 - Dr. Fatima Mechta-Grigoriou

11h40 - Dr. Julie Helft

Selected publications

• L. Zitvogel

Routy et al. (2018) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors Science

Andrews et al. (2021) Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade Nat Med

• W. H. Fridman

Petitprez et al. (2020) B cells are associated with survival and immunotherapy response in sarcoma Nature

Meylan et al. (2022) Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer Immunity

• F. Mechta-Grigoriou

Costa et al. (2018) Fibroblast heterogeneity and immunosuppressive environment in human breast cancer Cancer Cell

Kieffer et al. (2020) Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer Cancer Discov

• J. Helft

Helft et al. (2015) GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c⁺MHCII⁺ macrophages and DCs Immunity

Ramos et al. (2022) Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer Cell

Contacts: Jean-Philippe.Girard@ipbs.fr | Lucas.Blanchard@ipbs.fr